For all media enquiries please contact Katarina Janerud, 
Communications Manager: 

Tel: +46 8 440 50 50 
Direct: +46 8 440 50 69 
Mobile: +46 709 69 69 99
Fax. +46 8 611 79 98 

Jos Lamers appointed CEO of Unilabs

Oct 03, 2013

Geneva, Switzerland - Unilabs, a leading medical diagnostic services company, today announces that Jos Lamers has been appointed CEO succeeding Jean-Paul Rigaudeau, effective October 7, 2013.

Jos Lamers joins Unilabs as CEO, from his previous position as CEO of Nucletron, a radiotherapy company and global leader in brachytherapy that was acquired by Elekta in 2011. Prior to his CEO role at Nucletron, Jos was a Regional President and member of the Executive Management Board at Eurofins Scientific. He succeeds Jean-Paul Rigaudeau, who will be leaving after over four years of successfully leading the Company.

"The Company is pleased that Jos Lamers will join as CEO and we warmly welcome him to Unilabs. Jos has a proven track record of leading multi-national healthcare organizations, and his valuable experience makes him the ideal leader to build upon the Company's strong foundation and take Unilabs to its next stage of development," said Paul Hökfelt, Chairman of the Board of Unilabs

"Unilabs is a leader in diagnostics throughout Europe, and I am delighted to work with such a dynamic and growing company," said Jos Lamers.

"On behalf of the Board and the shareholders I would also like to thank Jean-Paul for his significant contribution in leading Unilabs through an exceptional period of growth and building a strong team over the last four years. His leadership has ensured Unilabs is in a solid position to continue building upon the position it has created," said Paul Hökfelt.

"I wish continued success to the Unilabs team, and I would like to thank my colleagues, partners and customers for these four years of intensive collaboration," said Jean-Paul Rigaudeau

Contact information:

Paul Hökfelt, Chairman of the Board of Unilabs
Phone: +41 22 7022 001
Investor relations:

About Unilabs:

We are one of Europe's leading suppliers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies and the general public. We operate laboratory and medical diagnostic imaging facilities in 11 countries: Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden, Switzerland and the United Kingdom. Our network of facilities provides us with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe. For more information please visit

About Nordic Capital Private Equity Funds

Since the start in 1989, Nordic Capital Private Equity Funds have invested in large and medium sized companies, primarily in Northern Europe. Through committed ownership and by targeting strategic development and operational improvements, Nordic Capital creates value in its investments. The funds invest in companies in Northern Europe and in selected investment opportunities internationally. They are based in Jersey, Channel Islands, and are advised by the NC Advisory companies in Sweden, Denmark, Finland, Norway, Germany and the UK. Additional information about Nordic Capital is available through its corporate website,

Back to news listings >